Name:	bhvn_MilestonePaymentPaidByCompanyUponSpecifiedRegulatoryMilestoneAchievement
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the amount of milestone payment to be paid by the company upon the achievement of specified commercial milestones and annual royalty payments based on net sales of products from patents.

No definition available.

Name:	bhvn_MilestonePaymentToBePaidByCompanyUponSpecifiedCommercialMilestoneAchievement
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the amount of milestone payment to be paid by the company upon the achievement of specified regulatory milestones and annual royalty payments based on net sales of products from patents.

No definition available.

Name:	bhvn_MilestonePaymentToBePaidByCompanyUponSpecifiedRegulatoryMilestoneAchievement
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the amount of milestone payment to be paid by the company upon the achievement of specified regulatory milestones and annual royalty payments based on net sales of products from patents other than the specified product.

No definition available.

Name:	bhvn_MilestonePaymentToBePaidByCompanyUponSpecifiedRegulatoryMilestoneAchievementForOtherThanSpecifiedProducts
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Milestone Payments, Required, Capitalized To Intangible Asset

No definition available.

Name:	bhvn_MilestonePaymentsRequiredCapitalizedToIntangibleAsset
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Represents the number of licensed products using the patent rights licensed from BMS.

No definition available.

Name:	bhvn_NumberOfLicensedProducts
Namespace Prefix:	bhvn_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Payment For Milestone Achievement

No definition available.

Name:	bhvn_PaymentForMilestoneAchievement
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment Required Due To Achievement Of Milestone

No definition available.

Name:	bhvn_PaymentRequiredDueToAchievementOfMilestone
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Payment Required Due To Commencement Of Phase One Clinical Trial

No definition available.

Name:	bhvn_PaymentRequiredDueToCommencementOfPhaseOneClinicalTrial
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment Required Due To Commencement Of Phase Two Clinical Trial

No definition available.

Name:	bhvn_PaymentRequiredDueToCommencementOfPhaseTwoClinicalTrial
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment To Be Paid By Company On Commencement Of Phase One Clinical Trial

No definition available.

Name:	bhvn_PaymentToBePaidByCompanyOnCommencementOfPhaseOneClinicalTrial
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment To Be Paid By Company On Commencement Of Phase Three Clinical Trial

No definition available.

Name:	bhvn_PaymentToBePaidByCompanyOnCommencementOfPhaseThreeClinicalTrial
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Payment To Be Paid By Company On Commencement Of Phase Two Clinical Trial

No definition available.

Name:	bhvn_PaymentToBePaidByCompanyOnCommencementOfPhaseTwoClinicalTrial
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

No definition available.

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Name:	srt_CounterpartyNameAxis=bhvn_BMSAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: